If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
934.00    -12.00 (-1.27%)
Bid:
932.00
Ask:
934.00
Spread: 2.00 (0.215%)
Market Cap: £508.20m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate change

25 Mar 2026 07:00

RNS Number : 9770X
JPMorgan Claverhouse IT PLC
25 March 2026
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Graham Oldroyd as a Non-Executive Director of the Company with effect from the conclusion of the Annual General Meeting to be held on 7th May 2026. On appointment, Mr Oldroyd will serve as Senior Independent Director (SID) and Chairman of the Management Engagement Committee.

 

Mr. Oldroyd is an experienced Director with strong international leadership profile in private equity and industry, combining wide sector knowledge and in-depth expertise in strategic investment, mergers and acquisitions, joint ventures and business development.

 

Mr. Oldroyd is currently a Non-Executive Director of Senior plc, Deputy Chairman of Videndum plc and Chairman of The Global Smaller Companies Trust PLC.

 

Mr. Oldroyd does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Oldroyd.

 

 

25th March 2026

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDXDBDDGLS
Date   Source Headline
20th Feb 202511:00 amRNSNet Asset Value(s)
19th Feb 202511:27 amRNSNet Asset Value(s)
18th Feb 20255:04 pmRNSTransaction in Own Shares
18th Feb 202511:02 amRNSNet Asset Value(s)
17th Feb 20255:22 pmRNSTransaction in Own Shares
17th Feb 202512:08 pmRNSGearing announcement
17th Feb 202511:00 amRNSNet Asset Value(s)
14th Feb 20255:03 pmRNSTransaction in Own Shares
14th Feb 202511:38 amRNSNet Asset Value(s)
13th Feb 202510:11 amRNSNet Asset Value(s)
12th Feb 20255:15 pmRNSTransaction in Own Shares
12th Feb 20253:15 pmRNSTen Largest Investments
12th Feb 202510:22 amRNSNet Asset Value(s)
11th Feb 202510:10 amRNSNet Asset Value(s)
10th Feb 20255:03 pmRNSTransaction in Own Shares
10th Feb 202511:29 amRNSGearing announcement
10th Feb 202510:56 amRNSNet Asset Value(s)
7th Feb 20255:07 pmRNSTransaction in Own Shares
7th Feb 202511:09 amRNSNet Asset Value(s)
6th Feb 202510:48 amRNSNet Asset Value(s)
5th Feb 20254:58 pmRNSTransaction in Own Shares
5th Feb 202510:22 amRNSNet Asset Value(s)
4th Feb 20254:59 pmRNSTransaction in Own Shares
4th Feb 202511:21 amRNSNet Asset Value(s)
3rd Feb 202512:41 pmRNSGearing Announcement
3rd Feb 202511:25 amRNSNet Asset Value(s)
3rd Feb 20259:48 amRNSTotal Voting Rights
31st Jan 20254:57 pmRNSTransaction in Own Shares
31st Jan 202510:16 amRNSNet Asset Value(s)
30th Jan 20255:24 pmRNSTransaction in Own Shares
30th Jan 202510:23 amRNSNet Asset Value(s)
29th Jan 20255:10 pmRNSTransaction in Own Shares
29th Jan 202510:33 amRNSNet Asset Value(s)
28th Jan 20255:05 pmRNSTransaction in Own Shares
28th Jan 202510:51 amRNSNet Asset Value(s)
27th Jan 20255:06 pmRNSTransaction in Own Shares
27th Jan 202511:38 amRNSGearing announcement
27th Jan 202510:30 amRNSNet Asset Value(s)
24th Jan 20254:53 pmRNSTransaction in Own Shares
24th Jan 202510:22 amRNSNet Asset Value(s)
23rd Jan 202510:51 amRNSNet Asset Value(s)
22nd Jan 20254:02 pmRNSFourth Quarterly Interim Dividend Declaration
22nd Jan 20253:48 pmRNSDirectorate Change
22nd Jan 202510:44 amRNSNet Asset Value(s)
21st Jan 20254:48 pmRNSTransaction in Own Shares
21st Jan 202510:39 amRNSNet Asset Value(s)
20th Jan 202512:11 pmRNSGearing announcement
20th Jan 202511:28 amRNSNet Asset Value(s)
17th Jan 20255:02 pmRNSTransaction in Own Shares
17th Jan 202510:40 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.